The therapeutic properties of light have been known for thousands of years, but it was only
in the last century that photodynamic therapy (PDT) was developed. At present, PDT is being …

The therapeutic use of light, as we know it, begins in 1900 when Raab reported that the
combination of acridine orange and light could destroy living organisms (paramecium)[1]. In …

Hypoxia, the hallmark of malignant tumors, has been recognized as a major obstacle for
photodynamic therapy (PDT). Precisely targeting cancer cells in intricate biological …

We report a photodynamic therapy driven by electrochemiluminescence (ECL). The
luminescence generated by Ru (bpy) 32+ and co‐reactant tripropylamine (TPA) pair acts as …

In photodynamic therapy, one of the problems limiting the use of many photosensitizers (PS)
is the difficulty in preparing pharmaceutical formulations that enable their parenteral …

Nanomaterials with well-defined size, shape, composition, and surface functionalities offer
multimodal and multifunctional platforms for various bioanalytical, bioimaging, and …

Presenting breakthrough research pertinent to scientists in a wide range of disciplines-from
medicine and biotechnology to cosmetics and pharmacy-this Second Edition provides …

An emerging class of targeted therapy relies on light as a spatially and temporally precise
stimulus. Photodynamic therapy (PDT) is a clinical example in which optical illumination …

Light has been widely used for cancer therapeutics such as photodynamic therapy (PDT)
and photothermal therapy. This paper describes a strategy called enzyme-enhanced …

Depuis sa découverte et son utilisation comme modérateur dans les réacteurs nucléaires,
les effets biologiques du D2O (eau lourde) ont largement été examinés, quoique souvent de …